EUVIMEDEUVIMED entdecken
Crossref

Electrospun Lacrimal Stent for Synergistic Anti‐inflammatory and Antioxidant Therapy via Macrophage Polarization and Microenvironment Remodeling

Lu Han, Yingying Gong, Fangliang Luo, Zhengchao Yuan, Hao Feng, Shutao Ma, Mohamed El-Newehy, Meera Moydeen Abdulhameed, Nurbiya Abduriyim, Xinyi Lai, Xiumei Mo iD, Qinghua Qiu

Advanced Healthcare Materials · 2026

DOI: 10.1002/adhm.202505809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Lu Han und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Advanced Fiber Materials Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biol…. Hauptthemen laut MEDLINE: Macrophages, Anti-Inflammatory Agents, Antioxidants, Lacrimal Apparatus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Science and Technology Commission of Shanghai Municipality, China, Shanghai Tongren Hospital, China, King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Obstructive lacrimal duct disease has long been a clinical challenge due to the limitations of traditional silicone stents, which are functionally simple, non‐degradable, and prone to fibrosis‐induced restenosis. In this study, we present a breakthrough approach in the development of a multifunctional, drug‐loaded, biodegradable lacrimal duct stent based on electrospinning technology. By integrating mesoporous polydopamine nanoparticles loaded with dexamethasone (MPDA@DEX) into a PLCL/Gel composite matrix, we successfully fabricated a biomimetic stent that exhibits desirable mechanical properties, hydrophilic surface characteristics, and controlled drug release capabilities. In vitro, the stent demonstrated excellent anti‐inflammatory and antioxidant activities, being associated with a shift of macrophages toward an M2‐like phenotype, significantly reducing intracellular ROS levels, and contributing to an inflammation‐repair balance via modulation of the MAPK/Hippo/FoxO signaling pathways. Transcriptomic sequencing further confirmed its ability to coordinate the regulation of the cellular transcription network, simultaneously suppressing pro‐inflammatory pathways while activating repair mechanisms. In vivo experiments further validated the stent's capacity to significantly reduce inflammation at the implantation site, inhibit collagen deposition, and promote angiogenesis. This research provides an innovative solution for lacrimal duct repair with active regulatory functions, representing a promising transition from “passive support” to “active repair” in therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesAnti-Inflammatory AgentsAntioxidantsLacrimal ApparatusDrug-Eluting StentsAnimalsDexamethasoneIndolesMiceNanoparticlesPolymers

Stichwörter der Autor:innen

anti‐inflammatory‐antioxidant synergistic therapybiodegradable materialselectrospinninglacrimal duct stentmacrophage polarizationtissue engineering

Substanzen

Anti-Inflammatory AgentsAntioxidantsDexamethasoneIndolespolydopaminePolymers

Autor:innen und Institutionen

  • State Key Laboratory of Advanced Fiber Materials Shanghai Engineering Research Center of Nano-Biomaterials and Regenerative Medicine, College of Biological Science and Medical Engineering, Donghua University, Shanghai,…
  • Institute of Biomaterials and Biomedicine, School of Food and Pharmacy, Shanghai Zhongqiao Vocational and Technical University, Shanghai, P. R. China.
  • Tongren Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Department of Chemistry, College of Science, King Saud University, Riyadh 11451, P.O. Box 2455, Saudi Arabia.
  • Bachu County Uyghur Medical Hospital, Kashi, Xinjiang, P. R. China.

ORCID-Profile: Xiumei Mo

Förderung

  • Science and Technology Commission of Shanghai Municipality, China
  • Shanghai Tongren Hospital, China
  • King Saud University

Zitieren

APA

Han, L., Gong, Y., Luo, F., Yuan, Z., Feng, H., Ma, S., El-Newehy, M., Abdulhameed, M. M., Abduriyim, N., Lai, X., Mo, X., & Qiu, Q. (2026). Electrospun Lacrimal Stent for Synergistic Anti‐inflammatory and Antioxidant Therapy via Macrophage Polarization and Microenvironment Remodeling. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505809

Vancouver

Han L, Gong Y, Luo F, Yuan Z, Feng H, Ma S, et al. Electrospun Lacrimal Stent for Synergistic Anti‐inflammatory and Antioxidant Therapy via Macrophage Polarization and Microenvironment Remodeling. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505809

BibTeX
@article{Han2026,
  author = {Han, Lu and Gong, Yingying and Luo, Fangliang and Yuan, Zhengchao and Feng, Hao and Ma, Shutao and El-Newehy, Mohamed and Abdulhameed, Meera Moydeen and Abduriyim, Nurbiya and Lai, Xinyi and Mo, Xiumei and Qiu, Qinghua},
  title = {Electrospun Lacrimal Stent for Synergistic Anti‐inflammatory and Antioxidant Therapy via Macrophage Polarization and Microenvironment Remodeling},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  doi = {10.1002/adhm.202505809}
}
Kostenlos starten →